All posts by: Michael Zand

‘Super Bowl of lung cancer immunotherapy‘
Cape Cod Times
Lung cancer is the second-most-common malignancy in the United States, after breast cancer. The American Cancer Society estimates that 234,000 people will be diagnosed with the disease this year, and 154,050 will die of it. Patients with newly …
Immunotherapy-first cancer treatment a ‘game-changer’, say scientistsSt. Lucia Times Online News (press release)
New studies give hope to people with lung cancerKOB
Immune therapy scores big win against lung cancer in studyThe Philadelphia Tribune
The Wellesley News –Chemical & Engineering News
all 12 news articles »